hematological findings in covid-19 and insights to stem cell therapy: from bench to practice

Context: as the covid-19 was spreading to all countries, its manifestations were identifying gradually, which were related to several organs. evidence acquisition: covid-19 is associated with distinct hematological changes, increased serum inflammatory markers, and coagulopathy. most of these changes are related to the patients’ prognosis and mortality, particularly in those with severe disease. results: firstly,wediscussed the associations between covid-19 clinical featuresandcomplications, andsecondly, its hematological findings and coagulopathy are investigated. conclusions: such associations not only may shed light on our prognostic view of patients with covid-19 but also will entail significant therapeutic implications. one of its key implications is to utilize the mesenchymal stem cells (mscs) to treat patients with covid-19. herein, this kind of novel therapy will be discussed, as well.